JD.com Inc. American Depositary Shares (JD)

FairStock Score: 45/100 — MIXED

Key Financials

Strengths

• Conservative balance sheet with debt-to-equity of just 0.36, providing financial flexibility
• Attractive 3.3% dividend yield providing steady income returns
• Established organization with 7,76,682 employees providing operational scale

Concerns

• Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
• Anemic revenue growth of 1.5% for a company of this size limits long-term upside
• Altman Z-Score of 0.8 places it in the financial distress zone—elevated bankruptcy risk

AI Analysis

JD.com Inc. American Depositary Shares is a mid-cap consumer cyclical company valued at $41.0 billion. Revenue stands at $1.3 trillion, though the company is currently unprofitable. From a quality standpoint, JD.com shows solid Piotroski F-Score of 6/9 and distressed Altman Z-Score of 0.8 warrants caution. On valuation, the stock is reasonably priced at 15.9x earnings, with offers a 49% margin of safety vs Graham Number of $59. Growth dynamics show revenue growing at 1.5% and profit growth of -127.5%. The 3.3% dividend yield adds an income component for patient holders. Our composite FairStock Score of 45/100 reflects mixed fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.

Bull Case

Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Sluggish 2% growth in a large-cap company leaves the stock vulnerable to de-rating if the market rotates toward higher-growth opportunities.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer